Natural Biocon (India) Ltd Financial Ratios

NATURAL · Healthcare · Current price ₹2.08

Full stock page
P/E ratio
-50.3x
P/B ratio
0.3x
ROE
-0.1%
ROCE
-0.1%
Debt / Equity
0.01
Dividend yield
0.0%
Ratio reference
RatioValueWhat it means
P/E-50.3xPrice paid per ₹1 of annual earnings — lower is cheaper (context-dependent).
P/B0.3xPrice relative to book value — <1 can signal deep value or trouble.
ROE-0.1%Return on equity — how much profit the company earns on shareholder capital.
ROCE-0.1%Return on capital employed — efficiency including debt. >15% is strong.
D/E0.01Leverage — higher means more debt-funded, riskier in downturns.
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Natural Biocon (India) Ltd's latest numbers.

Natural Biocon (India) Ltd profitability

Natural Biocon (India) Ltd generates a return on equity of -0.1% and a return on capital employed of -0.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.

Leverage & valuation

With a debt-to-equity of 0.01 and a P/E of -50.3x, Natural Biocon (India) Ltd is conservatively financed. Our overall business-quality score for the company is 4.6 / 10.

Understand the ratios

More on Natural Biocon (India) Ltd

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.